Newsroom

Miniature TIC
Vidéos
Antibiogo

[ANTIBIOGO] Antibiogo : A free diagnostic aid application to counter antibiotic resistance.

Événements
Antibiogo

The MSF Foundation will be present at Vivatech from June 15 to 18

The MSF Foundation will be at Viva Technology 2022 - June 15 to 18 in Paris. You will find Antibiogo on the Google.org booth.

Read more
App Antibiogo
Articles
Antibiogo

After 5 years of development, Antibiogo becomes the first medical device with CE marking developed by the MSF Foundation!

Read more
Événements
Antibiogo

Discover the work of the MSF Foundation at ChangeNow

At ChangeNow, on Friday, May 20 at 10 a.m., Dr. Nada Malou will present Antibiogo in the "Big Innovations that will change Health" session.

Read more
Articles
Antibiogo

Dr Nada Malou's intervention at the DIHAD 2022 conference

DIHAD is considered the first humanitarian and development event in the Middle East and has been bringing together leading humanitarian actors, government emergency management agencies, foundations and others since 2004. On the occasion of the 18th conference held from March 14-16, 2022, Dr Nada Malou presented Antibiogo.

 

Read more
KoutialaLab
Vidéos
Antibiogo

Antibiogo launch of the latest clinical evaluation in Mali

Headline

Antibiogo 3
Articles
Antibiogo

Antibiogo ISO 13485 Certified, a First for a Humanitarian Project

In 2025, the Antibiogo application is seeing wide deployment, extending beyond MSF field operations. After being adopted by all MSF laboratories in 2024, the tool has also been integrated by local health authorities in several countries: Burkina Faso, Comoros, Guinea, Liberia, Mali, Central African Republic, Democratic Republic of the Congo, and Benin. This expansion marks a new era for Antibiogo: scaling up.

At the same time, the project team continued efforts to reach the highest level of quality standards, culminating in obtaining ISO 13485 certification. This unprecedented level of requirement for an NGO project reflects the excellence of the management practices implemented for this medical device project, for which MSF Foundation is the legal manufacturer.

Read more

MSF Foundation in Video

More articles

News

More articles

Publications

  • Publications
    Étude Fièvre Jaune

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more
  • Publications
    Étude Fièvre Jaune

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more
More articles

Press Review

More articles
No news for now.